Stryker (SYK) Return on Capital Employed (2009 - 2026)
Stryker (SYK) posted quarterly Return on Capital Employed of 13.69% for Q2 2026, up 6388.0% year-over-year from 0.21% in Q2 2025, and up 11.84% on a QoQ basis from 12.24% in Q1 2026.
Stryker (SYK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Stryker has reported Return on Capital Employed for 18 years, with the latest figure at 13.69% in Q2 2026.
- Return on Capital Employed for Q2 2026 came in at 13.69%, up 6388.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 13.69% (up 6388.0% YoY), and the FY2025 annual result was 13.0%, up 209.0% from the prior year.
- Return on Capital Employed improved to 13.69% in Q2 2026, from 12.24% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 32.3% in Q4 2023 and troughed at 61.03% in Q2 2024.
- A 5-year average of 5.33% and a median of 11.56% in 2026 frame the typical range for Return on Capital Employed.
- The widest annual swing landed in 2024, when Return on Capital Employed slumped 8774 bps; it then soared 7980 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 9.43% in 2022, then soared by 243 bps to 32.3% in 2023, then slipped by 18 bps to 26.57% in 2024, then tumbled by 54 bps to 12.33% in 2025, then advanced by 11 bps to 13.69% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 13.69% in Q2 2026, 12.24% in Q1 2026, and 12.33% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 6.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.69% |
| Mar 31, 2026 | 12.24% |
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | 22.71% |
| Mar 31, 2025 | 26.14% |
| Dec 31, 2024 | 26.57% |
| Sep 30, 2024 | -57.11% |
| Jun 30, 2024 | -61.03% |
| Mar 31, 2024 | 31.70% |
| Dec 31, 2023 | 32.30% |
| Sep 30, 2023 | 30.63% |
| Jun 30, 2023 | 10.88% |
| Mar 31, 2023 | 10.10% |
| Dec 31, 2022 | 9.43% |
| Sep 30, 2022 | 9.05% |
| Jun 30, 2022 | 8.24% |
| Mar 31, 2022 | 8.30% |
| Dec 31, 2021 | 8.66% |
| Sep 30, 2021 | 8.53% |